Toyocamycin NEW
| Price | $39 | $59 | $115 |
| Package | 5mg | 10mg | 25mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-14 |
Product Details
| Product Name: Toyocamycin | CAS No.: 606-58-6 |
| Purity: 99.44% | Supply Ability: 10g |
| Release date: 2026/07/14 |
Product Introduction
Bioactivity
| Name | Toyocamycin |
| Description | Toyocamycin (Vengicide) is an adenosine analog produced by Actinomycetes, functioning as an XBP1 inhibitor and inhibiting IRE1α-induced ATP-dependent XBP1 mRNA cleavage (IC50: 80 nM), and induces apoptosis. |
| Storage | Store at low temperature,Keep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 122.5 mg/mL (420.59 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (34.33 mM), Solution. 10% DMSO+90% Saline : < 10 mg/mL (34.33 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. |
| Keywords | XBP1 activation | XBP1 | Toyocamycin | RNA synthesis | RNA Pol II phosphorylation | ribosome function | reactive oxygen species | mRNA cleavage | molecular docking | IRE1 | Inositol requiring enzyme 1 | Inhibitor | inhibit | Fungal | extracellular signal-regulated kinases | epigenetics | drug screening | Cyclin dependent kinase | CDKs | CDK9 inhibitor | CDK | cancer | Apoptosis | Antibiotic | adenosine analog |
| Inhibitors Related | Neomycin sulfate | Calcium Propionate | Stavudine | Aceglutamide | Kanamycin sulfate | Sulfamethoxazole sodium | Terbinafine hydrochloride | Benzyl propionate | Metronidazole | Doxycycline | Formamide | Alginic acid |
| Related Compound Libraries | Anti-Tumor Natural Product Library | Bioactive Compound Library | Kinase Inhibitor Library | Anti-Fungal Compound Library | Saccharide and Glycoside Natural Product Library | Natural Product Library | Inhibitor Library | Microbial Natural Product Library | Natural Product Library for HTS | Anti-infective Natural Product Library | Bioactive Compounds Library Max | Covalent Inhibitor Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY